Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01066325 · ClinicalTrials.gov registry record · Early Phase 1
Improving Flexibility With a Mindbody Approach
A Early Phase 1 study, sponsored by Parker Research Institute.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 45
- Enrollment target
NCT01066325: Completed Early Phase 1 study, sponsored by Parker Research Institute.
NCT01066325 is a Early Phase 1 study that has completed, run by Parker Research Institute. The registered enrollment target is 45 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (15% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01066325, a Early Phase 1 study, has completed, sponsored by Parker Research Institute.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
The objectives of this study are to investigate if Neuro Emotional Technique (NET) will impact back and leg flexibility over both the short-term and the long-term. It is hypothesized that NET will improve flexibility and that these changes are durable.
Interventions
- BEHAVIORAL Neuro Emotional Technique
- OTHER Stretching Instruction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2010-03 |
| Est. Completion | 2010-08 |
| Phase | Early Phase 1 |
What the finished NCT01066325 record still lists
NCT01066325 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (15% lower).
The record links to 0 conditions, and to 2 interventions - of which Neuro Emotional Technique is the first listed.
NCT01066325 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01066325 about?
NCT01066325 is a clinical study titled "Improving Flexibility With a Mindbody Approach". The objectives of this study are to investigate if Neuro Emotional Technique (NET) will impact back and leg flexibility over both the short-term and the long-term. It is hypothesized that NET will improve flexibility and that these changes are durable.
What is the current status of trial NCT01066325?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 45 participants. The study started on 2010-03. Estimated completion is 2010-08.
What interventions are being tested in trial NCT01066325?
The interventions under investigation include: Neuro Emotional Technique (BEHAVIORAL), Stretching Instruction (OTHER).
Who is sponsoring clinical trial NCT01066325?
This trial is sponsored by Parker Research Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01066325's enrollment target sits among peer trials
45 575th of 2000 higher than 1,412 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia